Gordon D MacFarlane is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of biochemical markers related to bone resorption. With a total of 2 patents, his work has implications for both research and clinical applications.

Latest Patents

One of MacFarlane's latest patents is focused on the synthesis of galactosylhydroxylysine. This compound serves as a terminal degradation product of the bone matrix and acts as a biochemical marker for bone resorption. The patent outlines a method for synthesizing galactosylhydroxylysine and describes the development of antibodies against this synthetically prepared compound. These antibodies are crucial for measuring galactosylhydroxylysine in biological fluids, providing valuable insights into bone health. Another significant patent is the immunophilin-bound immunosuppressant assay. This method allows for the determination of the concentration of an immunophilin ligand in blood samples by utilizing a nonionic detergent and a protease, followed by a concentration measurement.

Career Highlights

Throughout his career, MacFarlane has worked with various organizations, including Incstar Corporation. His innovative approaches have led to advancements in the understanding and measurement of biochemical markers, enhancing the field of biochemistry.

Collaborations

MacFarlane has collaborated with notable individuals such as Chaim Manor and Todd L Jensen. These partnerships have contributed to the development of his patents and the advancement of research in his areas of expertise.

Conclusion

Gordon D MacFarlane's contributions to the field of biochemistry through his patents and collaborations highlight his role as an innovator. His work continues to impact the understanding of bone resorption and the development of diagnostic methods.